Sanofi (SNY) Return on Invested Capital (2009 - 2026)

Sanofi has reported Return on Invested Capital for 18 years, with the latest figure at 0.02% in Q2 2026.

• Quarterly Return on Invested Capital rose 1.0% year-over-year to 0.02% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.02% (up 1.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital grew to 0.02% in Q2 2026 per SNY's latest filing, from 0.02% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.02% in Q3 2025 and troughed at 0.02% in Q4 2024.
• A 5-year average of 0.02% and a median of 0.02% in 2023 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2024: Return on Invested Capital rose 1 bps in 2022, then decreased 1 bps in 2024.
• Over 5 years, Return on Invested Capital stood at 0.02% in 2022, then climbed by 18 bps to 0.02% in 2023, then tumbled by 31 bps to 0.02% in 2024, then gained by 26 bps to 0.02% in 2025, then grew by 21 bps to 0.02% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.02%, 0.02%, and 0.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.